Nippon Kayaku Considers Promotional Measures for Biosimilars, Vascular Embolization Medical Devices

Masataka Nishikawa, General Manager, New Products Planning Department Nippon Kayaku established on June 1 the New Products Planning Department within its Pharmaceuticals Group in order to explore market penetration strategies for biosimilars and vascular embolizing agents for which approval/launch is...read more